ClinConnect ClinConnect Logo
Search / Trial NCT05091645

Translation and Cultural Adaptation of the Groningen Frailty Indicator (GFI) in Patients With Hip Fracture

Launched by UNIVERSITY OF THESSALY · Oct 22, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Frailty Syndrome Hip Fractures Cultural Adaptation Translation

ClinConnect Summary

This clinical trial is focused on translating and adapting a questionnaire called the Groningen Frailty Indicator (GFI) for Greek patients who have experienced a hip fracture. The GFI is designed to assess frailty, which is a condition that can make people more vulnerable to health issues, especially among older adults. By adapting this tool for the Greek population, the researchers hope to better understand and address the needs of patients recovering from hip fractures.

To participate in this study, you must be at least 65 years old, have suffered a hip fracture that requires surgery, and be able to communicate effectively. You should also not live in a care facility and need to agree to take part in the study. If you decide to join, you will fill out the GFI questionnaire, which will help healthcare providers learn more about your health and support your recovery. This research is currently looking for participants, and your involvement could help improve care for future patients in similar situations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • adult patients over 65 years old with hip fractures undergoing surgery
  • an ASA (American Society of Anesthesiologists) PS (physical status) I to III
  • non-institutionalized
  • able to communicate orally or in writing
  • consent to participate
  • Exclusion Criteria:
  • refused to participate
  • pathological hip fractures
  • institutionalized
  • patients with hip fracture treated conservatively
  • patients with severe cognitive dysfunction
  • patients with insufficient knowledge of the Greek language

About University Of Thessaly

The University of Thessaly is a distinguished academic institution located in Greece, recognized for its commitment to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials aimed at improving healthcare outcomes and fostering innovation in medical practices. Its dedicated research teams, equipped with state-of-the-art facilities and expertise across various fields, strive to contribute valuable insights to the scientific community while prioritizing patient safety and ethical standards in all clinical endeavors.

Locations

Larissa, , Greece

Patients applied

0 patients applied

Trial Officials

Eleni Arnaoutoglou, MD, PhD

Principal Investigator

University of Thessaly

Michael Hantes, MD, PhD

Principal Investigator

University of Thessaly

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials